Early Access — free while we kick the tires
EdgarHawk

Holly B. Kordasiewicz

EVP, Chief Development Officer

Officer

Latest: EVP, Chief Development Officer selling · June 2026

1 filing analyzed · 1 company · Latest 2026-06-16

Companies

Company Buys Sells Direction
IONIS PHARMACEUTICALS INC IONS 0 6 Net selling

Activity

June 2026
medium
Sell
60,846 shares
$4,466,428
Significance 6/10

EVP Holly Kordasiewicz sells 60,846 shares for $4,466,427.82 under 10b5-1 plan; retains 22,458 shares plus 21,000 stock options

Holly B. Kordasiewicz, EVP and Chief Development Officer, executed 2 separate sales totaling 60,846 shares for $4,466,427.82 on 2026-06-12 under a pre-arranged 10b5-1 trading plan adopted 2026-03-13. Her non-derivative holdings decreased from 83,304 shares to 22,458 shares (a 73.0% reduction), though she retains 21,000 shares in the form of non-qualified stock options. The company is currently unprofitable (net income of $-92,528,000 for the latest full fiscal year) despite strong revenue growth of 33.8% year-over-year and recent quarterly revenue of $246,091,000. The stock trades at $73.09, down 15.7% from its 52-week high of $86.74, placing this sale as a scheduled execution within a predetermined plan rather than a discretionary market-timing decision.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access